What's this? This is an unbiased just-the-facts news summary about Federal Food & Drug Administration, Neupro and Parkinson's disease. To see the full newsline, click the red tabs below. Love news? Become a contributor now!

9 May, 2007

Parkinson’s patch approved

Announcement0 Comments

The FDA approves Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver a drug called rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments